SCHEMBL4891938

SCHEMBL4891938

CCc1ccc(-n2cc(C(=O)O)c(=O)c3cnc(Nc4cccc(OCCCOC)c4)nc32)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 18/20 0.53
INSR P06213 1/20 0.44
PDGFRB P09619 1/20 0.44
KIT P10721 1/20 0.44
SRC P12931 1/20 0.44
FLT3 P36888 1/20 0.44
USP2 O75604 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C9 P11712 2/20 0.43
CLK4 Q9HAZ1 1/20 0.43
MEN1 O00255 1/20 0.42
CASP1 P29466 1/20 0.42
CYP2C19 P33261 1/20 0.42
CASP7 P55210 1/20 0.42
HBB P68871 1/20 0.42
KMT2A Q03164 1/20 0.42
HIF1A Q16665 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4572798 0.92 CSF1R (0.63) CSF1RINSRPDGFRBKITSRC
SCHEMBL4573696 0.89 CSF1R (0.63) CSF1RINSRPDGFRBKITSRC
SCHEMBL4892291 0.88 CSF1R (0.55) CSF1RINSRPDGFRBKITSRC
SCHEMBL4892771 0.85 CSF1R (0.58) CSF1RINSRPDGFRBKITSRC
SCHEMBL4891418 0.84 CSF1R (0.56) CSF1RINSRPDGFRBKITSRC
SCHEMBL4892188 0.82 CSF1R (0.53) CSF1RINSRPDGFRBKITSRC
SCHEMBL4892815 0.82 CSF1R (0.52) CSF1RINSRPDGFRBKITSRC
SCHEMBL4574248 0.81 CSF1R (0.65) CSF1RINSRPDGFRBKITSRC
SCHEMBL4884304 0.81 CSF1R (0.50) CSF1RINSRPDGFRBKITSRC
SCHEMBL4892096 0.81 CSF1R (0.67) CSF1RINSRPDGFRBKITSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080114007-A1 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114007-A1 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE FLT3, FES, ALK CSF1R 430/4885INSR 1526/4885PDGFRB 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.